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Summary. The high incidence of prostatic diseases,
including malignant tumors, makes the understanding of
prostate biology very important. Androgen deprivation,
blockade by orchiectomy, or chemical castration causes
prostate and tumor shrinkage. The gene networks
involved in a cell type-specific fashion are rather
unknown. This work was undertaken to identify genes
with annotated function in transcription regulation that
might define transitions in gene expression. A total of 15
potential regulatory genes were identified. Validation by
qRT-PCR showed that Zfp703 and Arid1a exhibit
expression maxima at day 1; Ash2l, Nelf, Pbx3, Eya2 at
day 4; Dmrt2 at day 5 and Lbh and Sox1 at day 7 after
castration. Using immunohistochemistry, we further
determined that PBX3 was found in both stromal and
epithelial cells, whereas ARID1A and NELF were
restricted to the epithelium, and DMRT2 and EYA2 were
exclusively found in the stroma. Though the proteins
ZFP703 and ASH2l were not found in any experimental
condition, their mRNAs were located by in situ
hybridization in both epithelium and stroma. In
conclusion, androgen deprivation triggers the expression
of temporally regulated gene sets in both epithelial and
stromal cells. These gene subsets will help establish the
regulatory gene expression programs orchestrating the
castration-induced remodeling of the prostate gland, and
represent putative targets to increase the efficacy of
androgen-deprivation to induce epithelial (and cancer)
cell death. 
Key words: Castration, Prostate, Stroma, Transcription
factors, Tissue remodeling
Introduction
Prostate cancer (PC) is the second leading cause of
cancer deaths in men, afflicting mostly the elderly. A
significant fraction of these men receive androgen
ablation by either surgical or chemical castration for the
treatment of the advanced disease and most of them will
die after progression of the disease to the more
aggressive and life threatening form, described by the
general term castration-resistant prostate cancer (CRPC).
Many molecular and chromosomal changes are
associated with PC, such as frequent rearrangements
within chromosome 21 (Tomlins et al., 2005). The
chromosomal rearrangements include the
TMPRSS2:ERG fusion gene, in particular, as well as
other androgen regulated genes at the 5’ end, and
different ETS genes at the 3’ end of the fused
construction, and occasionally replaced by BRAF or
RAF, as non-ETS members (Palanisamy et al., 2010).
More recently, generalized chromosomal rearrangements
have been described (Baca et al., 2013). Progress has
also been achieved in the demonstration of the clonal
progression to metastasis (Haffner et al., 2013), with
particular efforts resulting in a clear demonstration of
patient specific variation in gene expression, rather than
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showing an expected signature related to metastasis
(Holcomb et al., 2009). 
On the other hand, less is known of the mechanism
leading to CRPC. It is certainly dependent on
modifications of androgen receptor (AR) sensibility and
responsiveness, resulting from different in-frame
deletions within the gene, amplification, and altered
crosstalk with other signaling pathways, along with
modifications in the metabolic pathways to produce
androgens (Feldman and Feldman, 2001; Nyquist et al.,
2013; Yuan et al., 2014). In spite of the assumption that
androgen deprivation results in selection of androgen-
independent subpopulations in the tumor, it is difficult to
ascertain whether any particular alteration is already
present at the beginning of androgen deprivation therapy.
The physiology of the prostate gland’s adaptation to the
hypoandrogenic environment promoted by castration is
still poorly understood. In addition, the effects of
androgen deprivation on blocking cell proliferation and
promoting cell death have been definitively shown as
distinct events taking place at different androgen levels
(Isaacs, 1984). Progress in identifying regulators of cell
cycle progression in both PC and CRPC using cell
models revealed new avenues for the use of cytostatic
compounds in either case, such as PI3K/AKT and/or
mTOR inhibitors and blockers of AR ancillary factors,
such as GATA2 (Sunkel and Wang, 2014) .
The cell death response in the epithelium after
castration has been unequivocally demonstrated to be
independent of the AR (Kurita et al., 2001), but the
mechanism leading to epithelial cell apoptosis is
unknown. This suggests the existence of an underlying
regulatory network, triggered by androgen deprivation
and taking place in the hypoandrogenic environment, but
not directly dependent on AR function. Nonetheless, we
have reported before that epithelial desquamation (not
involving apoptosis) also contributes to cell deletion
after castration (Rosa-Ribeiro et al., 2014a) and that a
protease-dependent wave of apoptosis occurs at day 11
after castration (Bruni-Cardoso et al., 2010). These two
phenomena are distinct from the apoptosis occurring 3
days after castration. 
We have hypothesized that among genes that show
the typical pattern of being stimulated or repressed by
testosterone/dihydrotestosterone stimulation via the
androgen receptor and, hence, repressed or upregulated
after castration, respectively, there would exist genes
involved with coordinating the many phenomena taking
place after castration, including those setting the new
transcriptional states characteristic of the new cell
identities. In particular, the functioning of a
subpopulation of macrophages seems relevant to
preserve a non-inflammatory environment (Silva et al.,
2018). Furthermore, our own transcriptome and
bioinformatics study revealed a number of transcription
factors and transcription regulators regulating cell
survival, proliferation, and a new ‘immature signature”
(Rosa-Ribeiro et al., 2014b). Of note, we found NFκB
family members, MYBL2, EVI1, ELK1, and NFY as
important players. 
One limiting factor in the analysis of microarray data
is the incompleteness of information about the
investigated genes, which depend upon the available
information at the time of the investigation, and on
continuously evolving data banks and search software,
as well as careful annotation. One specific limitation of
mining published lists of differentially expressed genes
is shown by the ratio between known genes and
expression tags (EST). The report by Desai et al. (2004)
revealed 1496 differentially expressed transcripts in the
ventral lobe of the prostate gland (VP), 32% of them
were named genes. 
This work is part of our efforts to build up a
coherent sequence of regulatory steps coordinating the
different phenomena occurring after castration. To
overcome the intrinsic limitation of automatic gene
identifier tools, we manually searched the microarray
data set for genes with expression transients at days 1, 3,
5, or 7 after castration, determined their identity and then
validated the expression of 15 such genes by quantitative
real time PCR. We also considered that those genes
could be restricted to expression in particular cell types
within the organ, and thus used either
immunohistochemistry or in situ hybridization to
determine the expression location of seven of them in
the organ. The results revealed the kinetics of transiently
expressed gene subsets in both the epithelium and the
stroma of the prostate gland following castration, and
their distribution within the gland, and identified two
nuclear factors (NELF and ARID1A) contributing the
transcriptional identity of the epithelium.
Materials and methods
Methodology for gene identification and selection
In previous work we used DAVID to determine gene
identities and further explore the microarray data from
Desai et al. (2004), in a search for TF/TR. However,
only 32% of the genes were automatically retrieved and
we thought that important data could be still embedded
in the remaining ESTs. We then searched the remaining
non-identified ETS for differentially expressed genes
with peak variation at days 1, 3, 5, or 7 after castration,
and subsequently used the NCBI databank to correlate
the transcripts with their corresponding genes and then
searched for their annotated functions. A list of 15
transcription factors or transcription regulators was
retrieved. These genes were then validated by RT-PCR
and 7 of them showed transient expression and were
subsequently studied by immunohistochemistry or in situ
hybridization for identification of the gland compartment
or cell type distribution.
Animals
We used 90-day-old male Wistar rats (n=56,
weighing 380±20 g), with free access to food and water,
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in this study. Castration was achieved by bilateral
orchiectomy through a scrotal incision under ketamine
hydrochloride (80 mg/kg) and xylazine hydrochloride
(10 mg/kg) anesthesia. The animals were separated into
8 experimental groups (seven animals per group). Each
group of seven animals was divided into 2 subgroups i.e.
3 animals for morphology and related studies and 4
animals for RNA and protein extraction. The 2 lobules of
the gland were separated and each used for RNA or
protein extraction. An additional 8 rats were used for in
situ hybridization experiments, increasing the total
number of animals employed in this work to 64. The
experimental design, including sample size and
procedures, was approved by the State University of
Campinas Committee on the Use of Animals (Protocol
3000-1), according to the Brazilian College for Animal
Experimentation.
Prostate sample collection
Eppendorf tubes for the collection of ventral prostate
samples for RNA extraction were pre-treated with H2O2.
Ventral prostate samples were fixed in 4% para-
formaldehyde (PFA) in phosphate buffered saline (PBS)
for the morphological studies. The volume of the PFA
solution used was approximately 30 times the total
volume of the tissue fragments. For RNA and protein
extraction, the samples were immediately frozen in
liquid nitrogen and stored at -80°C until used. 
RNA extraction and reverse transcription
Ventral prostates were dissected under RNAse free
conditions. Thirty mg of tissue was used for total RNA
extraction. Subsequently, the tissue fragments were
extracted using Illustra RNAspin Mini Kits (GE
Healthcare, Germany) according to the manufacturer’s
instructions. RNA purity was analyzed by the
absorbance ratio 260/280 (values higher than 1.8) and by
electrophoresis in 1.2% agarose gel under denaturing
conditions. The RNA concentration in each sample was
determined in an Ultraspec 2100pro spectrophotometer
(Amersham Biosciences). Next, 5 μg of total RNA was
reverse transcribed with 200 U SuperScript III
(Invitrogen Corporation) and oligo (dT)12-18 primer(Invitrogen Corporation), according to the manufacturer
instructions. cDNA was quantified by spectro-
photometry.
Quantitative real time PCR (qRT-PCR)
Quantitative real-time polymerase chain reaction
(qRT–PCR) was performed using TaqMan Universal
PCR Master Mix (Applied Biosystems, Foster City, CA)
in the Applied Biosystems 7300. Inventoried assays
(Primer and FAM-conjugated probes) listed in Table 1,
were purchased from Applied Biosystems. cDNA (20
ng) was used in each reaction, according to universal
cycling conditions for the TaqMan system. The results
were normalized using the CT (threshold cycle) values
of the internal control glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) on the same plates. Gapdh was
chosen as internal control because it was found to show
the least standard deviation among the experimental
groups after testing 9 other controls for this specific
purpose. The equation ∆CT=CT (target gene) - CT(internal control) was employed for normalization of the
results. In order to quantify and acquire the fold-change
variation of our genes the mathematical model 2-∆∆CT
was utilized. Our genes and Gapdh assays had their
efficiencies calculated through the equation: 
E=10(-1/slope). All reactions were performed in technical
triplicates and the experiment was repeated twice. 
Immunohistochemistry 
PFA-fixed, paraffin-embedded tissues were cut into
5 μm sections, mounted on silane-treated slides,
dewaxed in xylene, and rehydrated. The sections were
briefly treated in a microwave oven in 10 mM citrate
buffer pH 6.0, then blocked with 3% H2O2 for 10 min,
followed by incubation with 6% bovine serum albumin
for 1 h. The sections were incubated overnight with
antibodies from Abcam or Thermo-Scientific diluted
1:1000 (DMRT2), 1:500 (for NELF), or 1:100 (for
ZNF703, ASH2L, ARID1A, EYA2 and PBX3). The
tissue-bound primary antibody was detected with a 488
Alexafluor-conjugated goat anti-rabbit Ig (Invitrogen
Carlsbad, CA, USA). Samples were analyzed in a Leica
750 fluorescence microscopy and the images captured
with a CCD camera. 
In situ mRNA hybridization
For mRNA localization, all solutions and materials
utilized were RNAse free. The probes were designed
using the Gene Runner 3.05 software (Hastings
Software, Inc., USA) according to mRNA sequences in
NCBI NM_001109425 and BF548399 for Zfp703 and
Ash2l, respectively. Two probes were synthesized for
each mRNA and were 5’-end labeled with Alexafluor
488 by Invitrogen Life Technologies (Carlsbad CA,
USA). Both sense and antisense sequences are given in
Table 2.
Frozen sections were air dried for 30 min at 37°C,
fixed in 4% PFA for 5 min, and washed in PBS twice for
5 min and twice in 2X SSC for 2 min. The sections were
incubated with Proteinase K (20 μg/mL) for 10 min at
room temperature and then washed twice for 5 min with
2x SSC buffer. The sections were incubated in 0.1 M
triethanolamine pH 8 (TEA Buffer) for 10 min and then
with 0.25% acetic anhydride in TEA buffer for 10 min
under magnetic stirring and then washed with 2x SSC.
The pre-hybridization solution was composed of 50%
formamide, 5x SSC, Denhardt’s solution (1x final
concentration), and completed with DEPC-treated water.
The sections were prehybridized for 3 hours without the
probe at 50°C in a humidified chamber with 50%
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formamide in SSPE. The probe mix included the probes
for each Zfp703 or Ash2l mRNAs and consisted of pre-
hybridization solution plus 400 ng of torula RNA and
200 ng of riboprobe mix (anti-sense or sense) (100 μL
for each tissue section). The mixture was placed on the
sections and incubated at 50°C overnight in a humidified
chamber. After 24 hours hybridization, the sections were
washed four times with 4x SSC buffer for 10 in PBS.
The sections were visualized with a Zeiss LSM780
confocal microscope. 
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Table 1. Gene names, accession numbers, sequences of reverse and forward primers, probes and the average melting temperature of the primers
used in the current study.
S.No Gene Name Accession No Primer/Gene Code Sequence
Average Melting
Temperature(Tm) °C
1 Zinc finger protein 703 NM_001109425
Znf703_F TGGTGGCTGGAGGTCTTGAG 63.6Znf703_R GCGGGTTGTTTTTGTGGAGTA
Znf703_P AGAATTCTGTTGTGCTGTGTG ---
2 Absent, small or homeotic-like (Drosophila) BF548399
Ash2_F AGGGTGTGGCTTACAAGGATATTT 62.2Ash2_R CGTGCAGCTCTTGTACAGTGAGA
Ash2_P TGAAGGTGTTTACTTCCCAG ---
3 Basic helix-loop-helix transcription factor NM_021592
bLHL_F CTCTCGCTGCCTACAGAAACCT 63.45bLHL_R CAAGGCTGGAGATGACACGAA
bLHL_P CAAGAAGTCCGCAGGTC ---
4 D site of albumin promoter(albumin D-box) binding protein NM_012543
Dbp_F GCAGCCAAGAGGTCGAGAGA 64.15Dbp_R AGGCTGCCCGCACAGAT
Dbp_P AAGACTCAAGGAGAACCAGA ---
5 Nelf nasal embryonic factor AJ293697
Nelf_F GGAGAGGAAGCGTCGGAAAC 63.35Nelf_R TGCGGAAGTTCCTCTGGATT
Nelf_P AGAATGATTCCGCGTCTG ---
6 Similar to limb-bud and heart AA800701
Loc683626_F CCCCTGACCTGCTCAGACA 63.7Loc683626_R GGGTGGCTTCTTCCTTTTGC
Loc683626_P TTGTACAACATGGTCTAGTGAC ---
7 Pre-B-cell leukemia homeobox 3 BF398712
Pbx3_F CACGGTCAAACCCCAGACA 63.15Pbx3_R TTGCCCTGAGATGAAGATCTTG
Pbx3_P TCTTGTTTTCACCTCTGTAGC ---
8 Eyes absent homolog 2(Drosophila) AW918854
Eya2_F GAGCAAGGAGCCAAAAAGCA 62.95Eya2_R AGGTCAGCGTGGCAGGATAT
Eya2_P AACATGCCGTTCTGGAG ---
9 Zinc finger protein 219 BE105452
zfp219_F TCCTTAACAGCAGCACATCCTCTAC 62.9
zfp219_R GGCAGAGGTGAGGGTCAAAG
zfp219_P AGCCCTAGGACCCCGT ---
10 SRY (sex determining 
region Y)-box 17 BF551118
Sox17_F GGGTTTGCTCCCCACCAT 63.05Sox17_R TTTCTTTGGATCAAGTTGGTGAGAT
Sox17_P ACTGTCCAGTTTTAGCCAGT ---
11 LIM and cysteine-rich domains 1 AW919666
12-Lmcd_F GCCTGCTGATGGACTCCAA 63.35Lmcd_R ATGCCGTCTCCACCTTTCAC
Lmcd_P TATGCCACTCTTACTGCCAG ---
12 Double sex and mab-3 
related transcription factor 2 AW918208
Dmrt2_F CGGAATTTGTCCCCCATTG 63.6Dmrt2_R TTGGTTAAGACGTGCCCTTGA
Dmrt2_P TGATATGGACTGTCTGGCAG ---
13 High mobility group box 1 BE107162
Hmgb1_F AAAACCCACAAAATTGCCAAA 61.75Hmgb1_R CCCGAACTCATTCATTAATCATGTT
Hmgb1_P TGTTCCCTAAACTAAGCAGAT ---
14 Treacher Collins-Franceschetti
syndrome 1 homolog (human) BE108177
Tcof1_F AGCAGTTCTGTCAGGACCTTCAT 63.4Tcof1_R CCCTGGCCCCTGAGTGA
Tcof1_P ACAGAGGCCTGCACC ---
15 AT rich interactive domain 1A (SWI-like) AW536019
Arid1a_F CAAAGCGAGACACAGCTATTTAATCT 61.95Arid1a_R CCTGTAGAGCATCGCACCAA
Arid1a_P TTGCCAGACGTCGCC ---
16 Zinc finger protein 142 BE101212
znf142_F GGTGGTCACTGGAGATTCAGTCA 63.05
znf142_R GGCTTGGACTAAACCATTGATTTC
znf142_P AGGTCAAACCATAACACTAC ---
17 Similar to Forkhead box protein F1 AA817785
FKHK5_F ATACCCTCAGACTGTCCCTTTGAT 61.65FKHK5_R CGGCATCTGTGACACATATTTTAAA
FKHK5_P CAGTGCAGAAAGGAG ---
Statistical analyses
Data are reported as the mean ± standard deviation
(SD). Differences between groups were determined by
one-way analysis of variance (ANOVA), followed by the
post hoc Tukey’s test. Differences were considered to be
significant when p≤0.05. Experiments were performed in
triplicate. 
Results
Identification of new TF and TR differentially expressed
in the rat ventral prostate after castration
In this work, we have extended our search by
manually identifying mRNAs with transient expression
at days 1, 3, or 5 after castration, or with an expression
maximum at day 7, and then selected those with
annotated TF or TR function, or had homologies to
known TF or TR in other species. This search retrieved
15 new genes, which were further validated by qRT-
PCR. 
mRNA levels for the selected genes at different time
points after castration
Castration promoted a marked reduction in ventral
prostate weight. Seven days after surgery, the organ was
reduced to about 33% of its original size. There was a
small increase in the relative weight of the gland 24-28
hours after castration, which has been observed before
(Garcia-Florez et al., 2005; Bruni-Cardoso et al., 2010)
and was attributed to initial edema, possibly due to
increased blood vessel permeability (Shabsigh et al.,
1998).
We have collected the ventral prostate from these
samples for mRNA extraction and qRT-PCR
determination of their content variation, daily up to 7
days after castration. 
qRT-PCR was performed for all of the selected
genes using probes and primers mentioned in Table 1.
The results showed several patterns of expression
variation after castration, considering their changes in
expression along time (Fig. 1). Of the genes, 7 of them
(Znf703, Ash2l, Nelf, Pbx3, Eya2, Dmrt2, and Arid1a)
showed the expected transiently increased expression
after castration and were further studied by
immunohistochemistry for the determination of their
location in either prostate epithelium and/or stroma. 
Location of the proteins in the gland
Of the 15 selected genes, 7 were confirmed to have
transient expression within the first week after castration
and were further analyzed with respect to their
compartmentalization in the prostate gland. Fig. 2 shows
the representative IHC results for these eight TFs.
DMRT2 showed a very restricted distribution 5 days
after castration in stromal fibroblast-like cells (Fig. 2a).
Immunohistochemistry for DMRT2, at 6 and 7 days after
1029
Transcription regulators in the prostate gland
Table 2. Sequences of probes for in situ hybridization.
Name of Factor Accession # Sequence of probe
Znf703 BE101212
Sense 1 5’ CATCCTCTCTACACCTATGGCTTCATGCTG
Antisense 1 5’ CAGCATGAAGCCATAGGTGTAGAGAGGATG
Sense 2 5’ TTGTTTGGTTTGGACTGATTTGGTATTGAG
Antisense 2 5’ CTCAATACCAAATCAGTCCAAACCAAACAA
Ash2 AW918208
Sense 1 5' TTCAAATACCCTCCAAAGGACGTCACT
Antisense 1 5' AGTGACGTCCTTTGGAGGGTATTTGAA
Sense 2 5' GATCCATGCTTCTTATGACATTGTGAAAT
Antisense 2 5' ATTTCACAATGTCATAAGAAGCATGGATC
Table 3. Summary of the major findings.
Name of Factor Transcript Day of peak expression Fold- change Gene Product Gene Product in
accession code after castration in Epithelial Cells Stromal cells
Arid1a AW536019 1 1.4 + -
Ash2l* BF548399 4 4.5 + +
Dmrt2 AW918208 5 2.5 - +
Eya2 AW918854 4 1.4 - +
Nelf AJ293697 4 2 + -
Pbx3 BF398712 4 1.8 + +
Znf703* NM_001109425 1-4 3 + +
*mRNA has been shown by In Situ hybridization in tissue.
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Fig. 1. Expression profile of the 15 selected
genes as determined by qRT-PCR. (a) Znf703;
(b) Ash2l; (c) Lbh; (d) Pbx3; (e) Nelf (f) Zfp219;
(g) Sox17 (h) Eya2; (i) Dmrt2; (j) Hmgb1; (k)
Lmcd1; (l) Arid1a; (m) Tcof1; (n) Fkx. Arid1a
showed peak expression 1 day after castration.
Ash2l, Nelf, Pbx3, Eya showed expression
peaks at day 4 after castration. Dmrt2 showed
expression peak at day 5 after castration. bLHL
showed expression peak at day 7 after
castration. Sox17 and Fkx showed progressively
increased expression after castration. Zfp219,
Lmcd1 and Tcof remained invariable. Dpb
showed an oscillatory expression pattern. Data are expressed as the mean ± SD (n=3). * is showing statistical difference among the groups.
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Fig. 2. Immunohistochemical localization of ZNF142, DMRT2
(a), EYA2 (b), NELF (c), PBX3 (d), and ARID1A (e) in the rat
ventral prostate of non-castrated controls and at the day of
peak expression. a. Little staining for DMRT2 was found in
non-castrated controls (left). The arrows show a fibroblast-like
cell, showing expression of DMRT2 5 days after castration
(middle), which is seen in the detail (right). b. No staining for
EYA2 was observed in non-castrated control (left), while large
stromal cells expressing EYA2 were found 4 days after
castration (arrows in the middle panel). A detail of these cells
is shown in the right panel. c. The non-castrated controls
showed very faint labeling for NELF (left), while staining
appeared increased 4 days after castration in the epithelial
cells and showed a slight accumulation in the nuclei of the
epithelial cells (middle panel and detail in the right). d. PBX3
labeling was absent in the non-castrated controls (left), while
it was found in both the epithelial and stromal cells 4 days
after castration (middle). In particular, the staining was
associated at the cell membrane, and showed clear
distribution along the cell perimeter (detail in the right panel).
e. ARID1A labeling was seen in the non-castrated control
epithelium and was predominantly located in the cytoplasm
(left). After castration it was predominantly found in the cell
nucleus (middle panel and detail in the right). Ep: epithelium;
St: stroma. Scale bars: 50 μm in the overall views and 25 μm
in the details.
castration, showed no staining. EYA2 was located in
stromal cells 4 days after castration exclusively (Fig.
2b). A very faint staining for NELF was observed in the
epithelial cells 4 days after castration, and no expression
was observed in the control sample (Fig. 2c). PBX3 was
located in both epithelial and stromal cells 4 days after
castration, whereas only a very weak staining was
visible in the control samples, with a clear association
with the cell periphery (Fig. 2d). ARID1A was found in
the epithelium of both non-castrated controls and 1 day
after castration (Fig. 2e). Immunostaining vanished at
days 3 and 4 after castration.
Location of Znf703 and Ash2l mRNAs in the gland
Znf703 and Ash2l showed the expected transient
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Fig. 3. In situ hybridization for the localization of Znf703 (a) and Ash2l mRNAs (b) in non-castrated controls (middle panels) and in castrated animals at
the day of peak expression (day 1 for Znf703 and day 4 for Ash2l (right panels). Sense probes were used as negative controls (left panels).
Hybridization with anti-sense probes was found in both epithelium and stroma for Znf703 and Ash2l mRNAs. Scale bars: 25 μm in the middle and right
panels and 50 μm in the negative controls (left panels).
kinetics after castration, but could not be found at the
protein level using either immunohistochemistry or
western blotting. It is important to mention that the
antibodies employed here could identify each protein in
a positive control or in the neonatal prostate (Nishan et
al., 2015). To identify Znf703 and Ash2l transcripts
within the gland, we performed in situ hybridization.
The results showed the presence of both Znf703 and
Ash2l mRNAs in the epithelium and stroma in the non-
castrated controls as well as in castrated animals at day 1
for Znf703, and day 4 for Ash2l (Fig. 3). 
Results are summarized in Table 3.
Discussion
Using qRT-PCR, we have determined the variation
in mRNA levels for 15 genes manually selected from the
results by Desai et al. (2004) and found 7 of them to
show transient increases within the first week after
castration. The products for these 7 genes were located
in the gland, and subsets were determined to be located
in either the epithelium or stroma. ARID1A and NELF
were found exclusively in the epithelium, whereas EYA2
and DMRT2 were restricted to stromal cells and
ZNF703, ASH2L, and PBX3 were found in both
compartments (Table 1).
The prostate gland is highly dependent on androgens
for its development, growth, and functioning and
castration promotes the active and progressive
inactivation of the gland (Isaacs, 1984; Kyprianou and
Isaacs, 1988; Isaacs et al., 1994). The current study
showed a 67% reduction in the weight of VP 7 days after
castration, which was consistent with previous
quantification in the same system (Bruni-Cardoso et al.,
2010). Analyses of long-term (100 days) androgen
deprivation showed that the organ shrank to about 5% of
the prostate weight in age-matched control animals
(Antonioli et al., 2007). 
However, the prostate adaptation to the
hypoandrogenic environment is complex. This
complexity reflects the ability of the organ to adjust its
activity to the overall reproductive function, which is
particularly evident in seasonal breeders and/or in
species with social male hierarchy. While the major
factors controlling these variations, such as light-dark
cycles, temperature, and food availability in the former
and unknown factors in the latter, androgens are chief
executives of gland activity. Accordingly, in a previous
study, the authors found a series of circadian rhythm
genes differentially expressed after castration (Bmal1,
Clock, Per2 and Nr1d1) (Kawamura et al., 2014). 
In an apparent paradox, and perhaps appearing as a
manifestation of the existence of a refined and yet ill-
known physiological control, prostate epithelial cell
death occurring after castration is dissociated from the
central mastery of androgen signaling. This was
indicated by the fact that cell death was independent of
the expression of AR in the epithelial cells (Kurita et al.,
2001), as well as by the notable differences between the
ventral and dorso-lateral lobes of the rodent prostate,
characterized by reduced levels of apoptosis and the
relative scarcity of genes affected by castration in the
dorso-lateral lobes, as compared with the ventral lobes
(Kwong et al., 1999; Desai et al., 2004).
These differences are indicative that hidden
mechanisms are imperative for adjusting the gland to
varying levels of circulating androgens. More recently,
insights into these mechanisms have been appearing, as
new transcription factors are enrolled in the observed
cell and extracellular matrix changes (Sunkel and Wang,
2014; Rosa-Ribeiro et al., 2014b). Additional layers of
AR regulation have been reported for cultured cells,
including the transcription factors GATA2, FoxA1, and
MED1-dependent DNA loop formation (Sunkel and
Wang, 2014), while NFkB family members, MYBL1/2,
EVI-1 among others reveal a “transcription factor
signature”, characterizing the new epithelial and stromal
cell identities in the hypoandrogenic environment (Rosa-
Ribeiro et al., 2014b).
In general, reports in the literature about the 7 genes
identified here are scarce, providing exciting
opportunities. 
Dmrt2 is expressed in presomitic mesoderm and
developing somites (Kim et al., 2003). In our study, it
showed the expected expression profile with peak
expression 5 days after castration. The Dmrt2 protein
was found 5 days after castration in fibroblast-like cells,
suggesting that stroma-specific regulatory networks are
active after castration.
Eyes absent homolog (EYA) proteins play pivotal
roles in organ formation during development by
interacting with Sine Oculis (SO) and Dachshund (DAC)
(Jung et al., 2010). Drosophila eyes absent homologue 2
(EYA2) in Drosophila is a conserved transcriptional
regulator (Zhang et al., 2005). Furthermore, loss-of-
function mutants cause partial or complete absence of
the compound eye. Eya2 triggers rapid apoptosis in
interleukin-3 dependent 32D.3 murine myeloid cells
(Wesley-Clark et al., 2002). Consistent with previous
studies on the expression profile of Eya2, the identified
expression pattern suggests Eya2 to be a master switch
regulatory gene in the adult prostate with peak
expression four days after castration. Considering that
Eya2 protein expression was located by
immunohistochemistry in the stromal cells after
castration, it is unlikely to be a direct regulator of
epithelial apoptosis. 
Nelf is a guidance molecule for olfactory axon
projections and neurophilic migration of luteinizing
hormone releasing hormone cells (LHRH) (Kramer and
Wray, 2000). LHRH regulates developmental migration
and projection of gonadotropin releasing hormone
(GnRH3) neurons in zebrafish (Palevitch et al., 2009).
Its function in the prostate is largely unknown and
demands further studies. 
PBX3 is another TF with an expression profile
showing peak expression 4 days after castration. Pbx3 is
expressed in both stroma and epithelium 4 days after
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castration and seems to be involved in the various
structural and physiological changes that take place after
castration. Pbx3 has been reported to be up-regulated in
prostate cancer and post-transcriptionally regulated by
androgen through Let-7d, an androgen regulated
microRNA (Ramberg et al., 2011). 
Arid1a is part of the SWI/SNF chromatin-
remodeling complex. ARID1A has been reported as a
tumor suppressor (Jones et al., 2010). It showed a
transient increase 1 day after castration. As determined
by immunohistochemistry, ARID1A was found in a few
acini in both non-castrated control and castrated rats 1
day after surgery. Moreover, 2 days after castration, we
found a small number of cells expressing ARID1A, but
no staining was found 3 or 4 days after castration. This
TF seems to take part in the very early response to
castration, which, in association with its localized
expression in the gland of non-castrated animals, reveals
a possible association with transitions in chromatin
activity and makes ARID1A an interesting candidate for
further studies.
ZNF703 is a transcriptional repressor (Nakamura et
al., 2008) and a key regulator of breast cancer
progression (Slorach et al., 2011). Znf703 induces cell
proliferation and interferes with the TGFβ pathway. In
MCF7 cells, increased ZNF703 expression results in
activation of genes involved in stem cell self-renewal,
while in primary human mammary epithelial cells,
ZNF703 increases the ratio of luminal to basal
progenitors. ZNF703 over expression was also shown to
alter the regulation of proliferation and differentiation in
luminal breast tumors (Bazarov and Yaswen, 2011). Our
results show that Znf703 expression increased transiently
by days 1-4 after castration and that the mRNA was
found in both epithelium and stroma. These findings
suggest that ZNF703 is either present below the limit of
detection by immunohistochemistry or immediately
degraded after translation, a possibility that needs to be
checked experimentally. It will be interesting to
determine whether ZNF703 is necessary for any active
movement within the epithelial layer early after
castration that might be associated with the
reorganization of the basement membrane we reported
before (Carvalho and Line, 1996).
The absent small and homeotic (Ash2l) gene is a
member of the trithorax group of positive transcriptional
regulators of the homeotic genes (Amorós et al., 2002;
Cheng and Shearn, 2004). It showed a transient
expression profile with peak expression at day 4 after
castration. The approximately 4-fold change 4 days after
castration led us to speculate that ASH2L may have a
pivotal role in the cellular adaptation to androgen
deprivation. We could not localize the cells expressing
ASH2L in the tissue by immunohistochemistry, though
we could detect it in newborn prostate and in cultured
smooth muscle cells (results not shown). By in situ
hybridization we managed to determine the distribution
of mRNA in both non-castrated control and castrated rats
4 days after surgery. These results from qRT-PCR and in
situ hybridization suggest that either ASH2L protein is
rapidly degraded after its translation, or it might play
some role as RNA. 
In conclusion, we report the existence of epithelial
and stromal subsets of transiently expressed genes in the
prostate within the first week after castration. These
genes are poorly known and additional studies will help
to determine their function and will translate into
potentially druggable targets to approach specifically the
transition to the castration-resistant state of the human
disease, as well as contribute to identify regulatory
circuits downstream of AR activity (Nantermet et al.,
2004).
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